ArticleNPJ precision oncology2021

Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury.

Laura M Williamson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.